Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Rajasekhar M, Simpson JA, Ley B, Edler P, Chu CS, Abreha T, Awab GR, Baird JK, Bancone G, Barber BE, Grigg MJ, Hwang J, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Llanos-Cuentas A, Pukrittayakamee S, Rijal KR, Saravu K, Sutanto I, Taylor WRJ, Thriemer K, Watson JA, Guerin PJ, White NJ, Price RN, Commons RJ; WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group. Rajasekhar M, et al. Among authors: taylor wrj. Lancet Infect Dis. 2024 Feb;24(2):184-195. doi: 10.1016/S1473-3099(23)00431-0. Epub 2023 Sep 22. Lancet Infect Dis. 2024. PMID: 37748497 Free PMC article.
Malaria and the lung.
Taylor WR, White NJ. Taylor WR, et al. Clin Chest Med. 2002 Jun;23(2):457-68. doi: 10.1016/s0272-5231(02)00004-7. Clin Chest Med. 2002. PMID: 12092039 Review.
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.
Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ. Stepniewska K, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4271-80. doi: 10.1128/AAC.48.11.4271-4280.2004. Antimicrob Agents Chemother. 2004. PMID: 15504852 Free PMC article.
In vivo parasitological measures of artemisinin susceptibility.
Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ. Stepniewska K, et al. J Infect Dis. 2010 Feb 15;201(4):570-9. doi: 10.1086/650301. J Infect Dis. 2010. PMID: 20085495 Free PMC article.
Respiratory manifestations of malaria.
Taylor WRJ, Hanson J, Turner GDH, White NJ, Dondorp AM. Taylor WRJ, et al. Chest. 2012 Aug;142(2):492-505. doi: 10.1378/chest.11-2655. Chest. 2012. PMID: 22871759 Review.
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.
Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WR, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D. Witkowski B, et al. Lancet Infect Dis. 2013 Dec;13(12):1043-9. doi: 10.1016/S1473-3099(13)70252-4. Epub 2013 Sep 11. Lancet Infect Dis. 2013. PMID: 24035558 Free PMC article.
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.
White NJ, Ashley EA, Recht J, Delves MJ, Ruecker A, Smithuis FM, Eziefula AC, Bousema T, Drakeley C, Chotivanich K, Imwong M, Pukrittayakamee S, Prachumsri J, Chu C, Andolina C, Bancone G, Hien TT, Mayxay M, Taylor WR, von Seidlein L, Price RN, Barnes KI, Djimdé A, ter Kuile F, Gosling R, Chen I, Dhorda MJ, Stepniewska K, Guérin P, Woodrow CJ, Dondorp AM, Day NP, Nosten FH. White NJ, et al. Malar J. 2014 Dec 9;13:483. doi: 10.1186/1475-2875-13-483. Malar J. 2014. PMID: 25486998 Free PMC article. Review.
104 results